Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to describe the bone or joint infection due to Pseudomonas aeruginosa in patients having implant.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Description of BJI due to Pseudomonas aeruginosa | patients having bone and joint infection on implant due to Pseudomonas aeruginosa |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bone or joint infection due to Pseudomonas aeruginosa | Other | Description of bone or joint infection on implant due to Pseudomonas aeruginosa |
|
| Measure | Description | Time Frame |
|---|---|---|
| Description and rate of bone or joint infection on implant caused due to Pseudomonas aeruginosa | Description of the type of infection due to P. aeruginosa : patients and type of implant, profile of the bacterium, medical and chirurgical treatment, rate | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption) |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of adverse events occurring under medical treatment against Pseudomonas aeruginosa | description of adverse events occurring under medical treatment against Pseudomonas aeruginosa in BJI | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
patients having BJI on implant caused by Pseudomonas aeruginosa managed at the Croix Rousse Hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tristan FERRY, Md,PhD | Hospices Civils de Lyon Hôpital de la Croix-Rousse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospices Civils de Lyon | Lyon | 69004 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Rate of Treatment Failure |
Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin |
| Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption) |